This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Fondazione Per La Ricerca Sulla Fibrosi Cistica-on-Lus, Istituto Giannina Gaslini. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Frederico Sorana: Innovator in Cystic Fibrosis Treatment
Introduction
Frederico Sorana is a notable inventor based in Verona, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. His innovative work has led to the development of compounds that aim to improve the quality of life for individuals affected by this condition.
Latest Patents
Frederico Sorana holds 1 patent for his invention titled "Compounds and compositions for the treatment of cystic fibrosis." This patent relates to compounds of Formula (Ia) or pharmaceutically acceptable salts, hydrates, solvates, clathrates, polymorphs, and stereoisomers thereof. The invention further discloses a pharmaceutical composition comprising these compounds and their use in modulating CFTR protein or ABC protein activities.
Career Highlights
Throughout his career, Frederico has worked with esteemed institutions such as the Fondazione Istituto Italiano di Tecnologia and the Istituto Giannina Gaslini. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Frederico has collaborated with notable colleagues, including Tiziano Bandiera and Fabio Bertozzi. These partnerships have enriched his research and have been instrumental in advancing his innovative projects.
Conclusion
Frederico Sorana's contributions to the treatment of cystic fibrosis through his patented compounds highlight his dedication to improving healthcare solutions. His work continues to inspire future innovations in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile